Articles
Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation
Patients with unexplained mismatch repair deficiency are interested in updated genetic testing
Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden
Retrospective review of outcomes in patients with DNA-damage repair related pancreatic cancer
Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example
No hay comentarios:
Publicar un comentario